| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of EPHB2 mRNA" | 25614096 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of EPHB2 mRNA | 29067470 |
| D000393 | Air Pollutants | [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of EPHB2 gene | 28843141 |
| D001149 | Arsenates | [Atrazine co-treated with Arsenates] results in increased expression of EPHB2 mRNA | 18585445 |
| D001151 | Arsenic | Arsenic affects the methylation of EPHB2 gene | 25304211 |
| C015001 | arsenite | arsenite results in decreased methylation of EPHB2 promoter | 23974009 |
| D001280 | Atrazine | Atrazine results in increased expression of EPHB2 mRNA | 25929836 |
| D001280 | Atrazine | [Atrazine co-treated with Arsenates] results in increased expression of EPHB2 mRNA | 18585445 |
| C487081 | belinostat | belinostat results in decreased expression of EPHB2 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased mutagenesis of EPHB2 gene | 25435355 |
| C006780 | bisphenol A | bisphenol A results in decreased methylation of EPHB2 promoter | 27312807 |
| C006780 | bisphenol A | bisphenol A affects the expression of EPHB2 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of EPHB2 gene | 28505145 |
| D000069286 | Bortezomib | Bortezomib results in decreased expression of EPHB2 mRNA | 20977926 |
| C013418 | bromfenacoum | bromfenacoum results in increased expression of EPHB2 protein | 28903499 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of EPHB2 mRNA | 15336504 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of EPHB2 mRNA | 26079696 |
| D002104 | Cadmium | Cadmium results in increased expression of EPHB2 mRNA | 24376830 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in decreased expression of EPHB2 mRNA | 26272509 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EPHB2 gene | 20938992 |
| D060729 | Coal Ash | Coal Ash results in increased expression of EPHB2 mRNA | 19000753 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of EPHB2 mRNA | 19320972|1937684 |
| D003042 | Cocaine | Cocaine results in increased expression of EPHB2 mRNA | 15691709 |
| C055786 | columbamine | columbamine results in decreased expression of EPHB2 mRNA | 23124089 |
| C030973 | cupric oxide | cupric oxide results in decreased expression of EPHB2 mRNA | 22077320 |
| D003471 | Cuprizone | Cuprizone results in decreased expression of EPHB2 mRNA | 26577399 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of EPHB2 mRNA | 23640034 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of EPHB2 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of EPHB2 mRNA | 19561079|2739243 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of EPHB2 mRNA | 22609946 |
| C058705 | diethyl malate | diethyl malate affects the expression of EPHB2 mRNA | 24814887 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EPHB2 gene | 20938992 |
| C069837 | fullerene C60 | fullerene C60 results in decreased expression of EPHB2 mRNA | 19167457 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of EPHB2 mRNA | 28973697 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of EPHB2 mRNA | 27392435 |
| D007854 | Lead | Lead affects the expression of EPHB2 mRNA | 28903495 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of EPHB2 mRNA | 12057914 |
| C042720 | mercuric bromide | mercuric bromide results in decreased expression of EPHB2 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EPHB2 gene | 20938992 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of EPHB2 mRNA | 28001369 |
| C523799 | MRK 003 | EPHB2 results in increased susceptibility to MRK 003 | 19903844 |
| C568507 | N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide | "N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide results in decreased activity of EPHB2 protein" | 21888390 |
| C028007 | nickel monoxide | nickel monoxide results in decreased expression of EPHB2 mRNA | 19167457 |
| D009585 | Nitrogen Dioxide | [Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of EPHB2 gene | 28843141 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in decreased expression of EPHB2 mRNA | 26272509 |
| D010578 | Petroleum | Petroleum results in increased expression of EPHB2 mRNA | 25208076 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of EPHB2 mRNA | 26272509 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of EPHB2 mRNA | 20813756 |
| C545373 | ponatinib | ponatinib results in decreased activity of EPHB2 protein | 19878872 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of EPHB2 mRNA | 22714537 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in decreased expression of EPHB2 mRNA | 23608068 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of EPHB2 mRNA | 26079696 |
| D011441 | Propylthiouracil | Propylthiouracil affects the expression of EPHB2 mRNA | 24780913 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of EPHB2 mRNA | 24780913 |
| C017947 | sodium arsenite | sodium arsenite affects the methylation of EPHB2 gene | 28589171 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of EPHB2 mRNA | 17685462 |
| D012999 | Soman | Soman results in decreased expression of EPHB2 mRNA | 19281266 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of EPHB2 mRNA | 26377647 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of EPHB2 mRNA | 22298810 |
| C009495 | titanium dioxide | titanium dioxide results in decreased phosphorylation of EPHB2 protein | 21439344 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of EPHB2 mRNA | 16137721 |
| D014212 | Tretinoin | Tretinoin affects the expression of EPHB2 mRNA | 16251210 |
| D014227 | Triazines | Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of EPHB2 mRNA] | 27469509 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A affects the expression of EPHB2 mRNA | 28542535 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of EPHB2 mRNA | 24935251|2627250 |
| D014415 | Tunicamycin | Tunicamycin results in decreased expression of EPHB2 mRNA | 22378314 |
| D014520 | Urethane | Urethane results in increased expression of EPHB2 mRNA | 28818685 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of EPHB2 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of EPHB2 mRNA | 23179753|2627250 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of EPHB2 mRNA | 23179753 |
| D014638 | Vanadates | Vanadates results in increased expression of EPHB2 mRNA | 22714537 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in decreased expression of EPHB2 mRNA | 26272509|2718838 |
| D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical results in increased expression of EPHB2 mRNA" | 25208076 |